InsidersTradesSigma
Track the Phreesia, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Phreesia, Inc. has recorded 576 reports. Market capitalisation: €751m. The latest transaction was reported on 3 September 2026 (Attribution). Among the most active insiders: Linetsky David. All data is accessible without an account.
576
Insider Decl.
n/a
Thresholds
€12m
4 ops.
Buy Volume
€26m
232 ops.
Sell Volume
26Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,850 of 29,062 companies
42.3
score / 100
Value40
Quality45
FCF yld7.2%
Earn yld0.3%
EV/EBITDA29.0x
ROE2.9%
Gross mgn68%
Net mgn0.5%
Debt/EBITDA3.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 September 2026
Declarations576 total
192,000 shares0Common StockSEC:0001412408-26-000228:0
88,000 shares0Common StockSEC:0001412408-26-000229:0
192,000 shares0Common StockSEC:0001412408-26-000224:0
108,000 shares0Common StockSEC:0001412408-26-000225:0
43,000 shares0Common StockSEC:0001412408-26-000226:0
500,000 shares0Common StockSEC:0001412408-26-000227:0
192,000 shares0Common StockSEC:0001412408-26-000230:0
10,000 shares0Common StockSEC:0001412408-26-000230:1
182 shares@ US$12.280.0003% mcap0.0% of flowCommon StockSEC:0001412408-26-000205:0
685 shares@ US$10.730.0011% mcap1.2% of flowCommon StockSEC:0001412408-26-000203:0
377 shares@ US$10.730.0006% mcap1.1% of flowCommon StockSEC:0001412408-26-000202:0
69 shares@ US$10.760.0001% mcap0.0% of flowCommon StockSEC:0001412408-26-000199:0
1,247 shares@ US$10.920.0020% mcap1.6% of flowCommon StockSEC:0001412408-26-000198:1
937 shares@ US$10.760.0015% mcap1.2% of flowCommon StockSEC:0001412408-26-000198:0
536 shares@ US$10.700.0009% mcap2.2% of flowCommon StockSEC:0001412408-26-000195:0
1,247 shares@ US$10.920.0020% mcap1.6% of flowCommonSEC144:0001959173-26-005241
536 shares@ US$10.700.0008% mcap2.2% of flowCommonSEC144:0001959173-26-005214
1,371 shares@ US$10.840.0022% mcap1.8% of flowCommon StockSEC:0001412408-26-000194:0
1,371 shares@ US$10.840.0022% mcap1.9% of flowCommonSEC144:0001959173-26-005107
19,290 sharesCommon StockSEC:0001412408-26-000186:0
19,290 sharesCommon StockSEC:0001412408-26-000188:0
19,290 sharesCommon StockSEC:0001412408-26-000187:0
2,546 sharesCommon StockSEC:0001412408-26-000187:1
19,290 sharesCommon StockSEC:0001412408-26-000183:0
2,546 shares@ US$9.530.0036% mcap9.7% of flowCommonSEC144:0001959173-26-004869
25 of 576 declarations
关于 Phreesia, Inc.
Phreesia, Inc.(股票代码:PHR)是一家在美国纽约证券交易所(NYSE)上市的美国医疗保健技术公司。该公司成立于2005年,围绕一个明确的使命而建立:帮助患者在其护理中发挥更积极的作用,同时提高医疗保健提供者的运营效率。随着时间的推移,Phreesia已发展成为一个公认的医疗保健SaaS平台,专注于患者登记、患者激活、支付和医疗提供者组织的工作流自动化。 该公司的核心平台旨在数字化和简化患者就诊周围的许多行政步骤,包括注册、预约、支付、患者登记问卷和选定的临床支持工作流。Phreesia为美国数千个医疗提供者组织提供服务,使其在医疗保健软件领域具有有意义的全国足迹。管理层表示,该平台每年支持大约180 million患者就诊,这表明在广泛的客户群中具有显著的规模和经常性使用。 从竞争角度来看,Phreesia在医疗保健软件、患者参与和收入周期相关解决方案的交叉点处运营一个有吸引力但竞争激烈的细分市场。其市场地位得到集成产品套件、深入渗透医疗提供者工作流以及能够在患者旅程中创造价值而不是通过单点解决方案的支持。该公司的战略以扩大现有客户内的采用、添加相邻功能和加强支付相关产品为中心。 最近的发展很重要。2025年,Phreesia宣布收购AccessOne(一家医疗保健应收账款融资专家),以扩大其支付解决方案组合并改进医疗保健提供者的收款能力。此次收购符合公司从摄入和参与扩展到支付优化的更广泛努力。在最近的报告中,管理层还强调了运营杠杆的改善和继续朝着盈利性的进展,这与投资者评估公司从不惜一切代价增长向更纪律严明的执行过渡相关。 Phreesia也是从治理和市场信号角度值得关注的名称,因为SEC表格4内部人交易活动可以提供关于管理行为和股权所有权趋势的额外见解。对于法语使用者而言,关键要点是一个耐用的美国医疗保健软件特许经营权、专业产品集和对美国医疗保健系统长期数字化的敞口。
